BACKGROUND: We aimed to evaluate the prevalence of the metabolic syndrome (MetS) and its components in subjects with predominantly melancholic or non-melancholic depressive symptoms (DS) in a population-based study evaluating the efficacy of the Finnish diabetes prevention program (FIN-D2D). METHODS: Altogether, 4500 randomly-selected Finnish men and women aged 45-74 years were initially enrolled from the National Population Register: 2820 (63%) attended a health examination. Diagnosis of MetS was based on the criteria of the National Cholesterol Education Program (NCEP-ATPIII), and DS on the 21-item Beck Depression Inventory (BDI-21, ≥10 points). A summary score of the melancholic items in the BDI was used to divide the subjects with DS (N=432) into melancholic and a non-melancholic sub-groups. RESULTS: The prevalence of MetS was higher among subjects with non-melancholic DS compared to those with melancholic DS (69 % versus 55%, p 0.004). The prevalence of MetS among subjects without DS was 51%. The sex- and age-adjusted odd ratio (OR) for MetS was 2.10 (95%CI 1.62 to 2.73, p<0.001) when comparing the non-melancholic and non-depressed groups, 1.15 (95%CI 0.81 to 1.61, p=0.44) for the melancholic and non-depressed groups, and 1.84 (95%CI 1.20 to 2.80, p=0.005) for the non-melancholic and melancholic groups. LIMITATIONS: DS were based on a self-rating scale, and due to the cross-sectional design of our study, we cannot make inferences of causality. CONCLUSIONS: Compared to subjects without DS and those with melancholic DS, persons with non-melancholic DS may more frequently suffer from MetS.
BACKGROUND: We aimed to evaluate the prevalence of the metabolic syndrome (MetS) and its components in subjects with predominantly melancholic or non-melancholic depressive symptoms (DS) in a population-based study evaluating the efficacy of the Finnish diabetes prevention program (FIN-D2D). METHODS: Altogether, 4500 randomly-selected Finnish men and women aged 45-74 years were initially enrolled from the National Population Register: 2820 (63%) attended a health examination. Diagnosis of MetS was based on the criteria of the National Cholesterol Education Program (NCEP-ATPIII), and DS on the 21-item Beck Depression Inventory (BDI-21, ≥10 points). A summary score of the melancholic items in the BDI was used to divide the subjects with DS (N=432) into melancholic and a non-melancholic sub-groups. RESULTS: The prevalence of MetS was higher among subjects with non-melancholic DS compared to those with melancholic DS (69 % versus 55%, p 0.004). The prevalence of MetS among subjects without DS was 51%. The sex- and age-adjusted odd ratio (OR) for MetS was 2.10 (95%CI 1.62 to 2.73, p<0.001) when comparing the non-melancholic and non-depressed groups, 1.15 (95%CI 0.81 to 1.61, p=0.44) for the melancholic and non-depressed groups, and 1.84 (95%CI 1.20 to 2.80, p=0.005) for the non-melancholic and melancholic groups. LIMITATIONS: DS were based on a self-rating scale, and due to the cross-sectional design of our study, we cannot make inferences of causality. CONCLUSIONS: Compared to subjects without DS and those with melancholic DS, persons with non-melancholic DS may more frequently suffer from MetS.
Authors: Richard Musil; Florian Seemüller; Sebastian Meyer; Ilja Spellmann; Mazda Adli; Michael Bauer; Klaus-Thomas Kronmüller; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Robert Fisher; Wolfgang Gaebel; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel Journal: Int J Methods Psychiatr Res Date: 2017-06-14 Impact factor: 4.035
Authors: Linn K Kuehl; Christoph Muhtz; Kim Hinkelmann; Lucia Dettenborn; Katja Wingenfeld; Carsten Spitzer; Christian Otte Journal: Psychopharmacology (Berl) Date: 2016-07-27 Impact factor: 4.530
Authors: Jannica S Selenius; Niko S Wasenius; Hannu Kautiainen; Minna Salonen; Mikaela von Bonsdorff; Johan G Eriksson Journal: BMJ Open Diabetes Res Care Date: 2020-10
Authors: Mia D Eriksson; Johan G Eriksson; Hannu Kautiainen; Minna K Salonen; Tuija M Mikkola; Eero Kajantie; Niko Wasenius; Mikaela von Bonsdorff; Päivi Korhonen; Merja K Laine Journal: Ann Med Date: 2021-12 Impact factor: 5.348
Authors: Jussi Seppälä; Hannu Koponen; Hannu Kautiainen; Johan G Eriksson; Olli Kampman; Jaana Leiviskä; Satu Männistö; Pekka Mäntyselkä; Heikki Oksa; Yrjö Ovaskainen; Merja Viikki; Mauno Vanhala; Jussi Seppälä Journal: BMC Psychiatry Date: 2013-05-24 Impact factor: 3.630
Authors: Juliana R Bernardi; Charles F Ferreira; Gabrielle Senter; Rachel Krolow; Bianca W de Aguiar; André K Portella; Márcia Kauer-Sant'anna; Flávio Kapczinski; Carla Dalmaz; Marcelo Z Goldani; Patrícia P Silveira Journal: PLoS One Date: 2013-04-17 Impact factor: 3.240
Authors: Jörg Wiltink; Matthias Michal; Claus Jünger; Thomas Münzel; Philipp S Wild; Karl J Lackner; Maria Blettner; Norbert Pfeiffer; Elmar Brähler; Manfred E Beutel Journal: BMC Psychiatry Date: 2018-04-27 Impact factor: 3.630